NCT01099215View on ClinicalTrials.gov

Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
Peripheral Artery Disease
Interventions
BIOLOGICAL

PVS-10200

PVS-10200 is composed of allogeneic human aortic endothelial cells cultured in a gelatin matrix.

Trial Locations (3)

75015

Hopital Europeen Georges Pompidou, Paris

75018

Hopital Bichat, Paris

Unknown

Centre Hospitalier Universitaire d'Amiens, Amiens

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT01099215 - Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH) | Biotech Hunter | Biotech Hunter